{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:26:23Z","timestamp":1765275983573,"version":"3.46.0"},"reference-count":17,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n To analyse the duration of parenteral nutrition (PN) in patients treated for peritoneal malignancy with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) over a 2 year period at a single UK National referral centre.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A retrospective analysis of prospective data for all patients (n=321) who underwent CRS and HIPEC for peritoneal malignancy at the Peritoneal Malignancy Institute Basingstoke between April 1, 2013 and March 31, 2015.<\/jats:p>\n Duration of PN was compared between primary tumour site (appendix, colorectal, mesothelioma and other); completeness of CRS (complete CRS vs. major tumour debulking) and pre-operative nutritional assessment measures (including Mid Upper Arm Circumference).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The median duration of PN was 9 days (range 2\u201387 days). A total of 13\u2006% of patients had PN for less than 7 days and 6\u2006% for 5 days or less. There was no significant difference in duration of PN between the different tumour sites. Two factors that may increase the duration of PN include having major tumour debulking (MTD) and a baseline MUAC<23.5\u2006cm.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Most patients who underwent CRS and HIPEC for peritoneal malignancy required PN for more than 7 days with poor pre-operative nutritional status and inability to achieve complete cytoreduction predictors of prolonged PN requirements.<\/jats:p>\n <\/jats:sec>","DOI":"10.1515\/pp-2018-0123","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T05:02:45Z","timestamp":1538542965000},"source":"Crossref","is-referenced-by-count":8,"title":["Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?"],"prefix":"10.1515","volume":"3","author":[{"given":"David R.","family":"Swain","sequence":"first","affiliation":[{"name":"Peritoneal Malignancy Institute , Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Aldermaston Rd , Basingstoke RG24 9NA , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison L.","family":"Yates","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev P.","family":"Dayal","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios","family":"Tzivanakis","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom D.","family":"Cecil","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"Moran","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust , Basingstoke , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"2025120909201196869_j_pp-2018-0123_ref_001_w2aab3b7b2b1b6b1ab1b5b1Aa","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331.10.1007\/s10434-999-0727-710622499","DOI":"10.1007\/s10434-999-0727-7"},{"key":"2025120909201196869_j_pp-2018-0123_ref_002_w2aab3b7b2b1b6b1ab1b5b2Aa","doi-asserted-by":"crossref","unstructured":"Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications and long-term survival in 456 patients with pseudomyxoma peritonei of appendiceal origin. Dis Colon Rectum. 2011;54:293\u20139.10.1007\/DCR.0b013e318202f02621304299","DOI":"10.1007\/DCR.0b013e318202f026"},{"key":"2025120909201196869_j_pp-2018-0123_ref_003_w2aab3b7b2b1b6b1ab1b5b3Aa","doi-asserted-by":"crossref","unstructured":"Moran BJ, Cecil TD. The aetiology, clinical presentation, and management of pseudomyxoma peritonei. Sug Oncol Clin North Am. 2003;12:385\u2013603.","DOI":"10.1016\/S1055-3207(03)00026-7"},{"key":"2025120909201196869_j_pp-2018-0123_ref_004_w2aab3b7b2b1b6b1ab1b5b4Aa","doi-asserted-by":"crossref","unstructured":"Yan TD, Deraco M, Baratti D, Kusamuna S, Elias D, Glehen O, et\u2009al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.10.1200\/JCO.2009.23.964019917862","DOI":"10.1200\/JCO.2009.23.9640"},{"key":"2025120909201196869_j_pp-2018-0123_ref_005_w2aab3b7b2b1b6b1ab1b5b5Aa","doi-asserted-by":"crossref","unstructured":"Chua TC, Yan TD, Deraco M, Glehen O, Moran BJ, Sugarbaker PH. Peritoneal Surface Oncology Group. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg. 2011;98:60\u20134.10.1002\/bjs.726320872843","DOI":"10.1002\/bjs.7263"},{"key":"2025120909201196869_j_pp-2018-0123_ref_006_w2aab3b7b2b1b6b1ab1b5b6Aa","doi-asserted-by":"crossref","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et\u2009al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.10.1200\/JCO.2009.23.928519917863","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"2025120909201196869_j_pp-2018-0123_ref_007_w2aab3b7b2b1b6b1ab1b5b7Aa","doi-asserted-by":"crossref","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et\u2009al. French Surgical Association. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608\u201318.2073757310.1002\/cncr.25356","DOI":"10.1002\/cncr.25356"},{"key":"2025120909201196869_j_pp-2018-0123_ref_008_w2aab3b7b2b1b6b1ab1b5b8Aa","doi-asserted-by":"crossref","unstructured":"Moran BJ, Mukherjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg. 2006;93:100\u201304.","DOI":"10.1002\/bjs.5210"},{"key":"2025120909201196869_j_pp-2018-0123_ref_009_w2aab3b7b2b1b6b1ab1b5b9Aa","doi-asserted-by":"crossref","unstructured":"Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, et\u2009al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum. 2013;56:1366\u201372.10.1097\/DCR.0b013e3182a62b0d24201390","DOI":"10.1097\/DCR.0b013e3182a62b0d"},{"key":"2025120909201196869_j_pp-2018-0123_ref_010_w2aab3b7b2b1b6b1ab1b5c10Aa","unstructured":"NICE (National Institute for Health and Clinical Excellence). Nutrition support for adults. Clin Guidel. 2006;32:28\u201330."},{"key":"2025120909201196869_j_pp-2018-0123_ref_011_w2aab3b7b2b1b6b1ab1b5c11Aa","unstructured":"BAPEN. Malnutrition Universal Screening Tool\u2019 (The \u2018MUST\u2019). November 2003. Available at: www.bapen.org.uk\/the-must.htm"},{"key":"2025120909201196869_j_pp-2018-0123_ref_012_w2aab3b7b2b1b6b1ab1b5c12Aa","doi-asserted-by":"crossref","unstructured":"Henry CJK. Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr. 2005;8:1133\u201352.16277825","DOI":"10.1079\/PHN2005801"},{"key":"2025120909201196869_j_pp-2018-0123_ref_013_w2aab3b7b2b1b6b1ab1b5c13Aa","doi-asserted-by":"crossref","unstructured":"Mcquellon R, Gavazzi C, Piso P, Swain D, Levine E. Quality of life and nutritional assessment in Peritoneal Surface Malignancy (PSM): recommendations for care. J Surg Oncol. 2008;98:300\u201305.1872690310.1002\/jso.21050","DOI":"10.1002\/jso.21050"},{"key":"2025120909201196869_j_pp-2018-0123_ref_014_w2aab3b7b2b1b6b1ab1b5c14Aa","doi-asserted-by":"crossref","unstructured":"Vashi P, Gupta D, Lammersfield C, Braun D, Popiel B, Misra S, et\u2009al. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutrition. 2013;12:118.10.1186\/1475-2891-12-118","DOI":"10.1186\/1475-2891-12-118"},{"key":"2025120909201196869_j_pp-2018-0123_ref_015_w2aab3b7b2b1b6b1ab1b5c15Aa","doi-asserted-by":"crossref","unstructured":"Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, et\u2009al. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher admission rates. J Surg Res. 2016;200:158\u201363.10.1016\/j.jss.2015.08.003","DOI":"10.1016\/j.jss.2015.08.003"},{"key":"2025120909201196869_j_pp-2018-0123_ref_016_w2aab3b7b2b1b6b1ab1b5c16Aa","doi-asserted-by":"crossref","unstructured":"Harvey S, Parrott F, Harrison D, Bear DE, Seagaran E, Beale R, et\u2009al. Trial of the route of early nutritional support in critically Ill adults. N Engl J Med. 2014;371:1673\u201384.2527138910.1056\/NEJMoa1409860","DOI":"10.1056\/NEJMoa1409860"},{"key":"2025120909201196869_j_pp-2018-0123_ref_017_w2aab3b7b2b1b6b1ab1b5c17Aa","doi-asserted-by":"crossref","unstructured":"Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramanium A. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. INT J Colorectal Dis. 2015;17:772\u20138.10.1111\/codi.12975","DOI":"10.1111\/codi.12975"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/3\/4\/article-20180123.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0123\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:22:39Z","timestamp":1765275759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0123\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,20]]},"published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["10.1515\/pp-2018-0123"],"URL":"https:\/\/doi.org\/10.1515\/pp-2018-0123","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"type":"electronic","value":"2364-768X"},{"type":"print","value":"2364-7671"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"article-number":"20180123"}}